Vis enkel innførsel

dc.contributor.authorBjorvatn, Bjørn
dc.contributor.authorAxelsson, John
dc.contributor.authorPallesen, Ståle
dc.contributor.authorWaage, Siri
dc.contributor.authorVedaa, Øystein
dc.contributor.authorBlytt, Kjersti Marie
dc.contributor.authorBuchvold, Hogne Vikanes
dc.contributor.authorMoen, Bente Elisabeth
dc.contributor.authorThun, Eirunn
dc.coverage.spatialNorwayen_US
dc.date.accessioned2020-11-13T09:31:05Z
dc.date.available2020-11-13T09:31:05Z
dc.date.created2020-10-09T20:00:15Z
dc.date.issued2020
dc.identifier.citationBjorvatn, B., Axelsson, J., Pallesen, S., Waage, S., Vedaa, Ø., Blytt, K. M., Buchvold, H. V., Moen, B. E., & Thun, E. (2020). The association between shift work and immunological biomarkers in nurses. Frontiers in Public Health, 8, 415.en_US
dc.identifier.issn2296-2565
dc.identifier.urihttps://hdl.handle.net/11250/2687722
dc.description.abstractObjectives: Shift work is associated with several negative health effects. The underlying pathophysiological mechanisms are unclear, but low-grade inflammation has been suggested to play a role. This project aimed to determine whether levels of immunological biomarkers differ depending on work schedule, self-reported sleep duration, self-reported sleep quality, and presence of shift work disorder (study 1). Furthermore, we aimed to determine whether these biomarkers differ after a night of sleep vs. at the end of a night or a day shift (study 2). Methods: In study 1, 390 nurses provided blood samples after a night of sleep with the dried blood spot method. In study 2, a subset of 55 nurses also provided blood samples after a day shift and after a night shift. The following biomarkers were measured: interleukin-1alpha, interleukin-1beta, interleukin-4, interleukin-6, interleukin-8, interleukin-10, interleukin-13, monocyte chemoattractant protein-1, interferon-gamma, and tumor necrosis factor-alpha. Multiple linear regressions with adjustment for age, sex and body mass index (study 1) and ANOVAs with repeated measures (study 2) were conducted. Results: In study 1, neither work schedule, number of night shifts, number of quick returns (<11 h between consecutive shifts), sleep duration, poor sleep quality, nor shift work disorder were systematically associated with most of these biomarkers. Compared with day only work, day-evening work was associated with higher levels of IL-1alpha and IL-13, quick returns were associated with higher levels of IL-1beta and MCP-1, short sleep duration (<6 h) was associated with lower levels of IL-1beta and higher levels of TNF-alpha, and long sleep duration (8+ h) was associated with higher levels of IL-13. In study 2, IL-1beta levels were higher (large effect size) both after a day shift (14% increase) and a night shift (75% increase) compared with levels after a night of sleep. Similarly, TNF-alpha levels were higher (moderate-large effect size) after a day shift (50% increase) compared to after a night of sleep. In contrast, MCP-1 levels were lower (large effect size) both after a day shift (22% decrease) and a night shift (12% decrease) compared with after a night of sleep. Conclusions: We found some indications that shift work influenced immunological biomarkers. The results should be interpreted with caution due to limitations, e.g., related to the sampling procedure and to low levels of biomarkers in the blood samples.en_US
dc.language.isoengen_US
dc.publisherFrontiers Media S.A.en_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectshift work disorderen_US
dc.subjectimmunityen_US
dc.subjectinflammatory biomarkersen_US
dc.subjectcytokinesen_US
dc.subjectinterleukinen_US
dc.subjecttumor necrosis factor-alphaen_US
dc.subjectmonocyte chemoattractant protein-1en_US
dc.subjectblood spot methoden_US
dc.titleThe association between shift work and immunological biomarkers in nursesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright © 2020 Bjorvatn, Axelsson, Pallesen, Waage, Vedaa, Blytt, Buchvold, Moen and Thun.en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Helsefag: 800en_US
dc.source.pagenumber1-9en_US
dc.source.volume8:415en_US
dc.source.journalFrontiers In Public Healthen_US
dc.identifier.doi10.3389/fpubh.2020.00415
dc.identifier.cristin1838589
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal